![https://www.nfmidwest.org/wp-content/uploads/2023/10/Clinical-Trials-and-Research-icon-240x240.png](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img/https://www.nfmidwest.org/wp-content/uploads/2023/10/Clinical-Trials-and-Research-icon-240x240.png)
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)
Recursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients…
View Article